Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway

Autor: Han, Xue, Zhou, Wenwei, Zhang, Jiajia, Tu, Yu, Wei, Jiajia, Zheng, Ruyi, Zhu, Jian, Xu, Diyun, Ying, Huazhong, Wu, Gaojun, Shi, Qiaojuan, Liang, Guang
Zdroj: In International Immunopharmacology November 2023 124 Part B
Databáze: ScienceDirect